[ad_1]
New research shows outcomes are worse for Black patients with acute myeloid leukemia (AML) than white patients who received similar intensive therapy on clinical trials.
[ad_2]
Source link
[ad_1]
New research shows outcomes are worse for Black patients with acute myeloid leukemia (AML) than white patients who received similar intensive therapy on clinical trials.
[ad_2]
Source link